These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3932461)

  • 1. Neural modulation of immune function.
    Roszman TL; Brooks WH
    J Neuroimmunol; 1985 Nov; 10(1):59-69. PubMed ID: 3932461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.
    Cross RJ; Jackson JC; Brooks WH; Sparks DL; Markesbery WR; Roszman TL
    Immunology; 1986 Jan; 57(1):145-52. PubMed ID: 3080368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses.
    Hall NR; McClure JE; Hu SK; Tare NS; Seals CM; Goldstein AL
    Immunopharmacology; 1982 Oct; 5(1):39-48. PubMed ID: 6813289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation.
    Cross RJ; Roszman TL
    J Neuroimmunol; 1988 Aug; 19(1-2):33-45. PubMed ID: 3260905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroanatomic and neurotransmitter influences on immune function.
    Roszman TL; Jackson JC; Cross RJ; Titus MJ; Markesbery WR; Brooks WH
    J Immunol; 1985 Aug; 135(2 Suppl):769s-772s. PubMed ID: 2861232
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin.
    Benarroch EE; Balda MS; Finkielman S; Nahmod VE
    Neuropharmacology; 1983 Jan; 22(1):29-34. PubMed ID: 6405300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimmunomodulating activity of 6-hydroxydopamine in the developing chick embryo.
    Janković BD; Nikolić V; Kojić L
    Int J Neurosci; 1990 Apr; 51(3-4):215-7. PubMed ID: 2126257
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of the primary immune response by chemical sympathectomy.
    Kasahara K; Tanaka S; Ito T; Hamashima Y
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):687-94. PubMed ID: 870955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro.
    Fuchs BA; Campbell KS; Munson AE
    Cell Immunol; 1988 Dec; 117(2):339-51. PubMed ID: 2848630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro analysis of the immune capabilities of mice treated with immunosuppressive drugs.
    Lefkovits H; Reber K; Lefkovits I
    Int Arch Allergy Appl Immunol; 1974; 46(5):689-94. PubMed ID: 4601879
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of neural responses following suppression of the immune response by cyclophosphamide.
    Saphier D; Mor G; Ovadia H; Maimon A; Abramsky O
    Int J Neurosci; 1991; 56(1-4):277-82. PubMed ID: 1938144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic cholinergic receptors of rat lymphocytes: effect of antigen stimulation and local brain lesion.
    Gushchin GV; Jakovleva EE; Kataeva GV; Korneva EA; Gajewski M; Grabczewska E; Laskowska-Bozek H; Maslinski W; Ryzewski J
    Neuroimmunomodulation; 1994; 1(4):259-64. PubMed ID: 7489341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytologic shifts in the blood and spleen in immunized rats after the administration of antilymphocytic, antinuclear or antithymus serum].
    Kartasheva AL; Isachenkov VA; Polushkina EF; Kashkin KP
    Tsitologiia; 1970 Sep; 12(9):1156-63. PubMed ID: 5534544
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody plaque reduction in vitro and in vivo: a rapid assay for immunosuppressive agents.
    Gavin J; Waterbury W; Freidman H
    Transplant Proc; 1969 Mar; 1(1):413-5. PubMed ID: 4944252
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of T-suppressor cell activity by central nervous system catecholamine depletion.
    Cross RJ; Brooks WH; Roszman TL
    J Neurosci Res; 1987; 18(1):75-81. PubMed ID: 2960825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of central and peripheral norepinephrine on the antibody response.
    Vidal J
    Allergol Immunopathol (Madr); 1990; 18(1):41-6. PubMed ID: 2116717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogens and T-cell heterogeneity.
    Dutton RW
    Ann N Y Acad Sci; 1975 Feb; 249():43-6. PubMed ID: 1079431
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of in vitro immune response by treatment of spleen cell suspensions with anti-theta serum.
    Schimpl A; Wecker E
    Nature; 1970 Jun; 226(5252):1258-9. PubMed ID: 4912323
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid binding in the rostral hypothalamus is reduced following lesion of the ventral noradrenergic tract in female rats.
    Dyer RG; Parvizi N; Hollingsworth S; Mansfield S; Heavens RP; Bicknell RJ; Sirinathsinghji DJ
    Exp Brain Res; 1991; 85(1):230-4. PubMed ID: 1653147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The character of development of the immune response to sheep erythrocytes and parallel responses to exo- and endobiotics].
    Bykova AA; Iushkova TA
    Eksp Klin Farmakol; 1997; 60(3):58-60. PubMed ID: 9324402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.